Raia Drogasil revenue and financials
R$21.27Change from previous close: −0.09%Absolute change: −R$0.02
In the fiscal year ended December 2025, Raia Drogasil reported revenue of R$44.25B (+13.84% year over year). Net income was R$1.3B, a net margin of 2.9%.
Fiscal year ending in December. Sources and method on the page Methodology and sources.
At a glance
- Revenue growth
- +13.84%
- 2025 vs 2024
- Net income growth
- +8.08%
- 2025 vs 2024
- Net margin
- 2.9%
- 2024: 3.1%
Financial data
Amounts in millions of BRL; per-share values in BRL; shares in millions.
| Item | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 839 | 770 | 418 | 995 | 496 | 521 | 1,086 | 777 | 253 | 655 | 675 | 88.9 |
| Depreciation and amortization | 462 | 495 | 535 | 447 | 455 | 437 | 408 | 426 | 411 | 402 | 382 | 411 |
| Capital expenditure | -324 | -260 | -431 | -378 | -323 | -271 | -431 | -369 | -279 | -204 | -399 | -349 |
| Investing cash flow | -102 | -337 | -348 | -401 | -336 | -321 | -447 | -487 | -279 | -199 | -398 | -350 |
| Financing cash flow | -642 | -501 | 2.9 | -685 | -37.4 | -324 | -522 | -249 | -16.2 | -455 | -458 | 510 |
| Dividends paid | -246 | -0.5 | -344 | -0.1 | -308 | -0.1 | -236 | -1.1 | -237 | -0.2 | -239 | -0.3 |
| Share repurchases | -0.2 | -5.5 | -5.5 | — | — | 0.0 | -73.3 | — | — | — | — | — |
| Debt issued | 0.0 | 0.0 | 600 | — | 500 | 90.0 | 38.9 | 0.4 | 600 | 49.6 | 31.1 | 834 |
| Debt repaid | -395 | -495 | -247 | -684 | -229 | -414 | -252 | -366 | -261 | -505 | -250 | -324 |
| Net change in cash | 94.7 | -67.8 | 73.3 | -90.7 | 123 | -124 | 117 | 40.9 | -42.9 | 0.3 | -181 | 248 |
| Free cash flow | 514 | 510 | -12.7 | 617 | 173 | 251 | 655 | 408 | -26.8 | 451 | 276 | -260 |
| Levered free cash flow | 1,518 | 317 | -437 | 647 | -10.1 | 331 | 442 | 645 | -118 | 546 | 154 | -129 |